ClinicalTrials.gov
public full text
Public Domain
Transcranial Photobiomodulation With Patients With Parkinson's Disease
Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease. It is a progressive and disabling disease with significative impact on quality of life. Since it has no cure, available treatment is targeted to improve the symptoms due to a lack of dopamine in the central nervous system. The aim of the study was to see how transcranial photobiomodulation (tPBM) helped patients with Parkinson's disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Non Invasive Neuromodulation for Patients With Motor Control Disorders#918828
- The role of transcranial magnetic stimulation (TMS) in studies of vision, attention and cognition#642940
- Neuromodulation and Emerging Neurotechnologies: TMS, tDCS, DBS and Brain-Computer Interfaces Database#20907
- Bio Electro Stimulation Therapy for Parkinson's Disease#1137291
- Study of BDNF Pathway Biomarkers in the Cerebrospinal Fluid in Patients With Huntington's Disease#903251
Record · ID 915250
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive